"Nucleotidases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.
| Descriptor ID |
D009708
|
| MeSH Number(s) |
D08.811.277.352.650.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleotidases".
Below are MeSH descriptors whose meaning is more specific than "Nucleotidases".
This graph shows the total number of publications written about "Nucleotidases" by people in this website by year, and whether "Nucleotidases" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Nucleotidases" by people in Profiles.
-
ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear. Proc Natl Acad Sci U S A. 2008 Dec 02; 105(48):18770-5.
-
Induction of adenosine deaminase and 5' nucleotidase activity in cultured human blood monocytes and monocytic leukemia (THP-1) cells by differentiating agents. J Leukoc Biol. 1988 Sep; 44(3):205-11.
-
Bone marrow derived macrophages have polyamine and ectoenzyme phenotypes distinct from resident macrophages. Life Sci. 1988; 42(20):2019-27.
-
Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Br J Haematol. 1982 Sep; 52(1):97-104.
-
Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy. Cancer Treat Rep. 1982 Feb; 66(2):387-90.
-
Purine pathway enzyme abnormalities in acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 2):4821-23.
-
Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia. Blood. 1981 Aug; 58(2):330-2.
-
Glucocorticoid receptor concentrations and terminal transferase activity as indicators of prognosis in acute non-lymphocytic leukaemia. Br Med J (Clin Res Ed). 1981 Jun 06; 282(6279):1826-9.
-
Current concepts. Biochemical markers in lymphoid malignancy. N Engl J Med. 1980 Oct 16; 303(16):918-22.
-
Biochemical markers as indicators of prognosis in acute nonlymphocytic leukemia (ANLL). Adv Enzyme Regul. 1980; 19:287-93.